Filing News
Discover the latest filing news. Stay informed about significant regulatory filings, compliance updates, and their impacts on companies and industries. Get insights into legal and regulatory developments affecting business operations.
Jul 8, 2026 at 9:00 AM
Cantor Equity Partners I, Inc. and Bitcoin Standard Treasury Company Provide Update on Proposed Business Combination
NEW YORK--(BUSINESS WIRE)--Cantor Equity Partners I, Inc. (Nasdaq: CEPO) ("CEPO"), a special purpose acquisition company sponsored by an affiliate of Cantor Fitzgerald, today announced that CEPO and BSTR Holdings, Inc. ("BSTR") have agreed to work together on and are currently discussing a potential revised structure and amended terms for their previously announced proposed business combination. Such revised structure and amended terms for the proposed business combination are intended to bette...
Jul 6, 2026 at 9:57 PM
Mitsubishi UFJ Financial Group, Inc. Announces Filing of Annual Report on Form 20-F for the Year Ended March 31, 2026
TOKYO--(BUSINESS WIRE)--Mitsubishi UFJ Financial Group, Inc. (NYSE:MUFG)(TOKYO:8306)(ISIN:JP3902900004)(MUFG) hereby announces that it has filed its Annual Report on Form 20-F for the fiscal year ended March 31, 2026 (the “Annual Report”) with the U.S. Securities and Exchange Commission on July 6, 2026. The Annual Report includes MUFG’s audited consolidated financial statements prepared under U.S. GAAP as of and for the fiscal year ended March 31, 2026.The Annual Report is available on our websi...
Jul 6, 2026 at 4:04 PM
Vertex to Acquire Crinetics Pharmaceuticals
BOSTON & SAN DIEGO--(BUSINESS WIRE)--Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) and Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX), a global pharmaceutical company focused on the discovery, development and commercialization of novel therapeutics for endocrine diseases, today announced that the companies have entered into a definitive agreement under which Vertex will acquire Crinetics for $85.00 per share in cash, for a total equity value of approximately $10.0 billion, or approximately...
Jun 30, 2026 at 1:09 AM
FDA Grants Priority Review To Genentech’s Application for Enspryng, the First and Only At-Home Subcutaneous Treatment Option for Thyroid Eye Disease (TED)
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Genentech, a member of the Roche Group (SIX: RO, ROP; OTCQX: RHHBY), announced today that the U.S. Food and Drug Administration (FDA) has accepted and granted priority review to a supplemental Biologics License Application (sBLA) for Enspryng® (satralizumab) for the treatment of thyroid eye disease (TED). The filing acceptance is based on results from the two randomized, placebo-controlled global Phase III SatraGO studies assessing the safety and ef...
Jun 29, 2026 at 5:30 PM
SEEQC Files Registration Statement for Proposed Initial Public Offering
ELMSFORD, N.Y.--(BUSINESS WIRE)--SeeQC, Inc. ("SEEQC" or the “Company”), a quantum computing infrastructure company, today announced that it has publicly filed a registration statement on Form S-1 with the U.S. Securities and Exchange Commission (the "SEC") relating to a proposed initial public offering of shares of its common stock. The number of shares to be offered and the price range for the proposed offering have not yet been determined. SEEQC intends to list its common stock on the Nasdaq...
Jun 28, 2026 at 7:45 PM
Announcement Regarding Filing of Annual Report on Form 20-F with the U.S. Securities and Exchange Commission
NEW YORK--(BUSINESS WIRE)--Mizuho Financial Group, Inc. hereby announces that it filed an annual report on Form 20-F with the U.S. Securities and Exchange Commission on June 26, 2026. A copy of the Form 20-F annual report can be obtained at https://www.mizuhogroup.com/investors/financial-information?tab=form20f. Holders of Mizuho Financial Group, Inc. American Depository Receipts may request a complimentary hard copy of the completed audited financial statements by emailing twenty.f@mizuhofg.co...
Jun 26, 2026 at 11:10 AM
Dr. Reddy’s Laboratories Limited Announces Filing of Annual Report on Form 20-F
HYDERABAD, India--(BUSINESS WIRE)--Dr. Reddy’s Laboratories Limited announces filing of Annual Report on Form 20-F....
Jun 25, 2026 at 5:15 PM
Sherritt Files First Quarter 2026 Financial Statements, MD&A and Related Certifications
TORONTO--(BUSINESS WIRE)--Sherritt International Corporation (“Sherritt” or the “Corporation”) (TSX:S) today announced that it has filed its unaudited interim financial statements, management’s discussion and analysis and related officer certifications for the three months ended March 31, 2026 (collectively, the “Q1 2026 Filings”). The Q1 2026 Filings are available on SEDAR+ at www.sedarplus.ca. As previously disclosed, the Ontario Securities Commission (the “OSC”), as principal regulator, issu...
Jun 25, 2026 at 9:07 AM
CoStar Group Stockholders Overwhelmingly Reelect Director Nominees and Support Say-on-Pay at Annual Meeting of Stockholders
ARLINGTON, Va.--(BUSINESS WIRE)--CoStar Group, Inc. (NASDAQ: CSGP), a leading provider of online real estate marketplaces, information and analytics, today announced the results of its Annual Meeting of Stockholders (the "Annual Meeting") held on June 23, 2026. Stockholders approved all proposals presented at the meeting, including overwhelming support for all director nominees and approval of the Company’s advisory say-on-pay proposal. “Earlier this year, our Board, including three new directo...
Jun 24, 2026 at 3:00 PM
Statement From the Board of Brera Holdings Plc (“Solmate”)
DUBLIN--(BUSINESS WIRE)--Solmate (Nasdaq: SLMT) IRISH TAKEOVER PANEL OPENING POSITION DISCLOSURE UNDER RULE 8.1(a) AND (b) OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2022 BY AN OFFEROR OR AN OFFEREE 1. KEY INFORMATION (a) Full name of discloser: Brera Holdings Plc (b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named...
Media & Journalist Tools
From headlines to storylines—Business Wire delivers the news you need, when you need it.